bg
A

Allovir (ALVR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allovir (ALVR)

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more

  • USD0.81
  • USD0.81
  • USD0.78
  • USD6.12
  • 4.00%
  • --
  • 164.33k
  • 315.82k
  • 92M
  • 0.62
  • -79.30%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App